U.S. Markets open in 4 hrs 12 mins

Abacus Health Products Announces Release Date, Conference Call and Webcast Details for 2019 First Quarter Financial Results

WOONSOCKET, RI , May 21, 2019 /CNW/ - Abacus Health Products, Inc. (ABCS.CN) ("Abacus" or the "Company") will release its 2019 first quarter financial results on Thursday, May 30, 2019 , after market close. Management will host a conference call the following day, Friday, May 31, 2019 , at 10:00 AM Eastern Time to review the financial results.

Abacus Health Products, Inc. (CNW Group/Abacus Health Products)

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 1589844. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until June 7, 2019 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 1589844.

A live audio webcast of the conference call will be available at: https://event.on24.com/wcc/r/1987807/2997221656884D343FD84AFA94B2E9D9

Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. An archived replay of the webcast will be available for 90 days by clicking the link above.

About Abacus Health Products, Inc.

Abacus is a company engaged in the development and commercialization of over-the-counter (OTC) registered topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from Cannabis sativa L plant. Abacus' products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus' formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers two lines of products: (i) CBD CLINIC™, marketed to the professional practitioner market, and (ii) CBDMEDIC™, marketed to the consumer market. Abacus' products are offered across the United States and are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.

To learn more about Abacus, visit www.abacushp.com

SOURCE Abacus Health Products


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2019/21/c0057.html